LUNIT.IO: Keyword Density Checker

Total words: 1067 | 2-word phrases: 278 | 3-word phrases: 294 | 4-word phrases: 301

PAGE INFO

Title	Try to keep the title under 60 characters (33 characters) Lunit - Conquer Cancer through AI
Description	Try to keep the meta description between 50 - 160 characters (125 characters) Lunit develops AI solutions that detect early-stage cancer and optimize cancer treatment for saving lives through technology.
Keywords	Meta keywords are not recommended anymore (125 characters) ai, medical ai, medical artificial intelligence, x ray, chest x ray, lung, cancer, lung cancer, cad ai, cancer diagnosis, diagnosis, cancer ai, mammography, mammogram, ai imaging, tumor, radiology ai, radiology, ai imaging, mammogram screening
H1	H1 tag on the page (31 characters) Saving lives through technology

#	Keyword	Frequency	Density
1	partners partners partners	13	4.42%
2	researches researches researches	7	2.38%
3	awards awards awards	4	1.36%
4	20243 min read	2	0.68%
5	en contact us	2	0.68%
6	acquisition of volpara	2	0.68%
7	min read lunit	2	0.68%
8	quantification and multimodal	1	0.34%
9	her2 quantification and	1	0.34%
10	in her2 quantification	1	0.34%
11	innovations in her2	1	0.34%
12	asco 2024 including	1	0.34%
13	2024 including ai	1	0.34%
14	multimodal predictive models	1	0.34%
15	at asco 2024	1	0.34%
16	studies at asco	1	0.34%
17	7 studies at	1	0.34%
18	showcase 7 studies	1	0.34%
19	and multimodal predictive	1	0.34%
20	may 24 20245	1	0.34%
21	for immunotherapy response	1	0.34%
22	immunotherapy response may	1	0.34%
23	response may 24	1	0.34%
24	lunit to showcase	1	0.34%
25	24 20245 min	1	0.34%
26	20245 min read	1	0.34%
27	read lunit completes	1	0.34%
28	of volpara pioneering	1	0.34%
29	volpara pioneering nextlevel	1	0.34%
30	pioneering nextlevel of	1	0.34%

#	Keyword	Frequency	Density
1	partners partners partners partners	7	2.33%
2	researches researches researches researches	4	1.33%
3	awards awards awards awards	3	1.00%
4	at asco 2024 including	1	0.33%
5	eltoukhy ceo of guardant	1	0.33%
6	ceo of guardant health	1	0.33%
7	of guardant health learn	1	0.33%
8	guardant health learn more	1	0.33%
9	about lunit lunit to	1	0.33%
10	lunit lunit to showcase	1	0.33%
11	lunit to showcase 7	1	0.33%
12	to showcase 7 studies	1	0.33%
13	showcase 7 studies at	1	0.33%
14	7 studies at asco	1	0.33%
15	studies at asco 2024	1	0.33%
16	innovations in her2 quantification	1	0.33%
17	asco 2024 including ai	1	0.33%
18	products helmy eltoukhy ceo	1	0.33%
19	in her2 quantification and	1	0.33%
20	her2 quantification and multimodal	1	0.33%
21	quantification and multimodal predictive	1	0.33%
22	and multimodal predictive models	1	0.33%
23	for immunotherapy response may	1	0.33%
24	immunotherapy response may 24	1	0.33%
25	response may 24 20245	1	0.33%
26	may 24 20245 min	1	0.33%
27	24 20245 min read	1	0.33%
28	20245 min read lunit	1	0.33%
29	min read lunit completes	1	0.33%
30	helmy eltoukhy ceo of	1	0.33%
31	oncology products helmy eltoukhy	1	0.33%
32	of volpara pioneering nextlevel	1	0.33%
33	deputy director at the	1	0.33%
34	partners global business partners	1	0.33%
35	global business partners partners	1	0.33%
36	business partners partners partners	1	0.33%
37	partners partners partners what	1	0.33%
38	partners partners what will	1	0.33%
39	partners what will happen	1	0.33%
40	when ai professionals work	1	0.33%

#	URL	Whois	Check